The effect of ivermectin on the viral load and culture viability in early treatment of nonhospitalized patients with mild COVID-19 – a double-blind, randomized placebo-controlled trial-Reference-Cited by-同舟云学术

The effect of ivermectin on the viral load and culture viability in early treatment of nonhospitalized patients with mild COVID-19 – a double-blind, randomized placebo-controlled trial

Published:2022-09 Issue: Volume:122 Page:733-740
ISSN:1201-9712
Container-title:International Journal of Infectious Diseases
language:en
Short-container-title:International Journal of Infectious Diseases

Author:

Biber Asaf^ORCID,Harmelin Geva,Lev Dana,Ram Li,Shaham Amit^ORCID,Nemet Ital,Kliker Limor,Erster Oran^ORCID,Mandelboim Michal,Schwartz Eli

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference33 articles.

1. SARS-CoV-2 RNA identification in nasopharyngeal swabs: issues in pre-analytics;Basso;Clin Chem Lab Med,2020

2. Remdesivir significantly reduces SARS-CoV-2 viral load on nasopharyngeal swabs in hospitalized patients with COVID-19: A retrospective case–control study;Biancofiore;J Med Virol,2022

3. Ivermectin and COVID-19: A report in antiviral Research, widespread interest, an FDA warning, two letters to the editor and the authors' responses;Bray;Anti-viral Res,2020

4. Snapshot PCR surveillance for SARS-CoV-2 in hospital staff in England;Brown;J Infect,2020

5. ivermectin for prevention and treatment of COVID-19 infection: A systematic review, meta-analysis, and trial sequential analysis to inform clinical guidelines;Bryant;Am J Ther,2021

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of ivermectin for treatment of non-hospitalized COVID-19 patients: A systematic review and meta-analysis of 12 randomized controlled trials with 7,035 participants;International Journal of Antimicrobial Agents;2024-08

2. Efficacy and safety of oral ivermectin in the treatment of mild to moderate Covid-19 patients: a multi-centre double-blind randomized controlled clinical trial;BMC Infectious Diseases;2024-07-22

3. Utility of sustainable ratio derivative spectrophotometry for the concurrent assay of synergistic repurposed drugs for COVID-19 infections; Insilico pharmacokinetics proof;BMC Chemistry;2024-03-07

4. Ivermectin for treatment of COVID-19: A systematic review and meta-analysis;Heliyon;2024-03

5. The relationship between viral clearance rates and disease progression in early symptomatic COVID-19: a systematic review and meta-regression analysis;Journal of Antimicrobial Chemotherapy;2024-02-22